Vibozon Erdosteine Capsule

Adult dose

Adults: Administer 300 mg of erdosteine orally 2～3 times daily. When used for acute respiratory conditions, do not administer continuously for more than 10 days.

This medication should not be administered to specific patients. Patients allergic to this drug or its components should not use it. Patients with liver cirrhosis or certain enzyme deficiencies should avoid this medication, as its metabolites may be harmful to the body. Patients with peptic ulcers are also advised against taking this medication. Patients with severe renal impairment or severe liver impairment should not use this medication. Patients with mild to moderate liver dysfunction should use this medication with caution, and should ensure that the daily dose does not exceed 300 mg. Diabetic patients or those on a low-calorie diet should use the syrup form of this medication carefully. This medication contains a coloring agent known as Tartrazine, so patients allergic or having had hypersensitivity reactions to this coloring agent should take it cautiously. In case of overdose, symptoms such as sweating, dizziness, and facial flushing may occur. Neurological and respiratory system abnormal symptoms such as headache, cold symptoms, and dyspnea have been reported. Gastrointestinal side effects may include taste disturbances, nausea, vomiting, diarrhea, abdominal pain, and heartburn. Allergic reactions such as urticaria, erythema, and eczema may occur on the skin. Taking this medication in conjunction with cough medications may hinder the expulsion of phlegm and increase the risk of bronchial infections, so special caution should be taken when taking them together. Pregnant women or those who may become pregnant, as well as breastfeeding women, are advised not to take this medication. Although animal studies showed no special harm, safety in humans has not been adequately established. This medication should be kept out of the reach of children, and transferring it to another container should be avoided as it may cause risks of accidents and degradation of quality.

• Sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• altered taste
• nausea
• vomiting
• diarrhea

Drug interactions

This medication should be discussed with a doctor or pharmacist if taken with cough medications.

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps to preserve the efficacy and safety of the medication for a longer period.

Appearance

A hard capsule with a green upper part and a yellow lower part containing white powder.

Package unit

30 capsules/bottle, 300 capsules/bottle